Clinical Interests: Dr. Williams is the Director of Urologic Oncology. His clinical practice focuses on urologic cancers and specifically bladder cancer. He has a dedicated focus towards the multidisciplinary management of urologic cancers including the treatment of bladder, prostate, and testicular cancers which is supported by his research expertise in these areas.
Research Interests: Dr. Williams has expertise in health services research. His seminal research in comparative effectiveness regarding prostate cancer treatments has fueled his more recent interest in regards to discerning bladder cancer treatment patterns and optimizing outcomes. His research has been presented at the National Academies of Sciences, Engineering, and Medicine (previously known as the Institute of Medicine). He serves on numerous editorial boards and has >120 publications in high impact journals including JAMA Surgery which will help pave the way for further understanding and optimizing the care we deliver to patients.
Active: Department of Defense Peer Reviewed Cancer Research Program (PRCRP) Career Development Award (CA160108) "Risk of Bladder Cancer According to Agent Orange Exposure" PI: Stephen B. Williams, MD
Past: Center for Radiation Oncology Research Grant "Trends, Utilization and Risk of Hospitalization, Toxicity and Outcomes Following Radiotherapy Compared to Other Primary Treatments for Prostate Cancer" PI: Stephen B. Williams, MD; The University of Texas Medical Branch, Galveston, Texas, Institute for Translational Sciences, Clinical and Translational Science Award Mentored Career Development (KL2) Award; National Center for Advancing Translational Sciences, National Institutes of Health (KL2TR001441) "Identifying Variations in Bladder Cancer Treatments and Outcomes" PI: Stephen B. Williams, MD